Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three novel compounds in a humanized mouse model of psoriasis
NL-OMON35935Recruiting
- Sponsor
- Pfizer
- Start
- Jun 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of infliximab and tegtociclib in psoriasis and plaque psoriasis (4 arms), sponsored by Pfizer. Started Jun 2011; status: recruiting.
02
Drugs
infliximabtegtociclib
03
Conditions
psoriasisplaque psoriasis
Beyond the preview
Go deeper on NL-OMON35935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35935.